Doxorubicin (doxorubicin): Reviews and patient testimonials

Doxorubicin (Myocet) 50 mg powder, dispersion and solvent for concentrate for dispersion for infusion.

Myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in adult women.

Doxorubicin 2 mg/ml Concentrate for Solution for Infusion

Doxorubicin is indicated in the following neoplastic conditions,

Examples include:

- Small-cell lung cancer (SCLC)

- Breast cancer

- Advanced ovarian carcinoma

- Intravesically for bladder cancer

- Neoadjuvant and adjuvant therapy of osteosarcoma

- Advanced soft-tissue sarcoma in adults

- Ewing's sarcoma

- Hodgkin's disease

- Non-Hodgkin's lymphoma

- Acute lymphatic leukaemia

- Acute myeloblastic leukaemia

- Advanced multiple myeloma

- Advanced or recurrent endometrial carcinoma

- Wilms' tumour

- Advanced papillary/follicular thyroid cancer

- Anaplastic thyroid cancer

- Advanced neuroblastoma

Doxorubicin is frequently used in combination chemotherapy regimens with other cytotoxic drugs.

doxorubicin hydrochloride 2mg/ml solution for infusion

Doxorubicin is a cytotoxic medicinal product that is indicated in the following neoplastic conditions:

Small-cell lung cancer (SCLC)

Breast cancer

Recurrent ovarian carcinoma

Systemic treatment of local advanced or metastasized bladder carcinoma

Intravesical prophylaxis of recurrences of superficial bladder carcinoma following transurethral resection

Neoadjuvant and adjuvant therapy of osteosarcoma

Advanced soft-tissue sarcoma in adults

Ewing's sarcoma

Hodgkin's disease

Non-Hodgkin's lymphoma

Acute lymphatic leukaemia

Acute myeloblastic leukaemia

Advanced multiple myeloma

Advanced or recurrent endometrial carcinoma

Wilms' tumour

Advanced papillary/follicular thyroid cancer

Anaplastic thyroid cancer

Advanced neuroblastoma

Doxorubicin is frequently used in combination chemotherapy regimens with other cytostatic medicinal products.

Doxorubicin Solution for Injection

Antimitotic and cytotoxic. Doxorubicin has been used successfully to produce regression in a wide range of neoplastic conditions including acute leukaemia, lymphomas, soft-tissue and osteogenic sarcomas, paediatric malignancies and adult solid tumours; in particular breast and lung carcinomas.

Doxorubicin is frequently used in combination chemotherapy regimens with other cytotoxic drugs. Doxorubicin cannot be used as an antibacterial agent.

Route of administration: Injectable
Molecule: doxorubicin